A State of art In-house R&D facility, recognized by Department of Science and Technology, Govt. of India has recently been commissioned.Our emphasis will be on the development and commercialization of niche generic Active Pharmaceutical Ingredients.
Products Under Development
|Sr. No.||Name of API||CAS No.|
|1.||Dipivefrine Hydrochloride (BP / EP / USP)||64019-93-8|
|2.||Hydralazine Hydrochloride (IP / BP / EP / USP)||304-20-1|
|3.||Isoprenaline Sulphate (IP / BP / EP)||6700-39-6|